Remove Immune Response Remove In-Vitro Remove Life Science
article thumbnail

Lab to jab in 100 days: manufacturing flexibility for future rapid responses

Pharmaceutical Technology

The mission was first put forward during the UK’s G7 Presidency of June 2021, with support from representatives of the life sciences industry. billion towards the “pandemic-busting plan”, which involves the investigation of rapid response vaccine technologies. Single- and multi-nation funding opportunities flooded in.

article thumbnail

2021 Biotech IPOs Get Off to a Roaring Start

The Pharma Data

The year is starting off with a number of biopharma and life sciences initial public offerings (IPOs). Ortho Clinical Diagnostics is a leader in in vitro diagnostics. On January 12, its VITROS SARS-CoV-2 Antigen Test for mass-scale COVID-19 testing received FDA Emergency Use Authorization.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Budget 2021: Sunak focuses on vaccine development to restart economy

pharmaphorum

UK chancellor Rishi Sunak has announced a budget loaded with initiatives designed to kick-start the UK’s economy as it recovers from the coronavirus pandemic, with vaccine development, pharma and life sciences playing a key role. A scheme providing £500 payments to people self-isolating has been extended in England until the summer.

article thumbnail

Pfizer/BioNTech COVID-19 Vaccine Trial Results: Stellar, Long-Ranging Efficacies in Children and Against Variants

XTalks

The highly awaited COVID-19 vaccine trial results address what have been three highly contested areas of concern: is the COVID-19 vaccine safe for kids, is it effective against some of the new variants of SARS-CoV-2 and how long will immunity last? How Safe and Effective is Pfizer’s COVID-19 Vaccine for Kids?

article thumbnail

Ixchiq Wins FDA Approval as World’s First Chikungunya Vaccine

XTalks

The FDA says chikungunya is an emerging global health threat as at least 5 million cases of chikungunya virus infection have been reported in the last 15 years. According to the agency, the virus is found primarily in tropical and subtropical regions of Africa, Southeast Asia and parts of the Americas where the virus-carrying mosquitos are endemic.

article thumbnail

COVID-19 Vaccine Messaging: Why Vaccine Efficacies Can’t Be Compared and Shopped

XTalks

In light of this, vaccine makers and regulatory bodies will need to share vaccine data and science in a clear and rigorous manner in order to clearly communicate why there is no one best vaccine, and why each authorized vaccine is a superlative tool in battling COVID-19.

article thumbnail

How T Cell Tests Could Trump Antibody Tests in the Detection of COVID-19

XTalks

The cell-based tests are designed to identify specific T cells that are activated in response to a pathogen — which in this case would be SARS-CoV-2. Traditional antibody tests for uncovering past infections involve detection of antigen-specific antibodies produced during an immune response against a pathogen.